Literature DB >> 8838020

Effect of estrogens on plasma platelet-activating factor acetylhydrolase and the timing of parturition in the rat.

K Yasuda1, M Furukawa, J M Johnston.   

Abstract

In the present study we examined the effects of estrogens on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity in pregnant rats in an attempt to further define the role of platelet-activating factor (PAF) in parturition. The plasma PAF-AH activity decreased starting on Day 13 of pregnancy and reached its lowest level by Day 19 (36.5 +/- 5.7 nmol.min-1.ml-1 plasma, mean +/- SD). The maternal plasma PAF-AH activity rapidly increased to 67.3 +/- 3.5 nmol.min-1.ml-1 plasma by Day 2 postpartum, to 88.8 +/- 14.4 by Day 7, and to 109.1 +/- 4.4 by Day 21, returning to nonpregnant levels by Day 35 in the dams that were allowed to nurse through Day 21. The PAF-AH activity did not increase in dams from which the pups were removed 2 days after delivery. When 17 alpha-ethynylestradiol (0.25 mg/kg) was administered s.c. to pregnant rats for 3 days starting at Day 17 of pregnancy, the plasma PAF-AH activity in the animals decreased by 80% on Day 19, and the rats delivered prematurely on Day 21. When a similar dose of 17 alpha-ethynylestradiol was injected into the pregnant rats for 3 days starting on Day 15, the enzyme activity again decreased by approximately 80% on Day 17 and Day 19 of pregnancy; however, it returned to a value similar to that seen in the controls by Day 21, and the time at which the treated rats delivered was similar to that for the control animals. These observations provide further support for a role of PAF and PAF-AH and their possible regulation by estrogens in the initiation and maintenance of parturition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838020     DOI: 10.1095/biolreprod54.1.224

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

Review 1.  A Cross-Species Analysis of Animal Models for the Investigation of Preterm Birth Mechanisms.

Authors:  Brian W Nielsen; Elizabeth A Bonney; Bradley D Pearce; Leah Rae Donahue; Indra Neil Sarkar
Journal:  Reprod Sci       Date:  2015-09-16       Impact factor: 3.060

2.  Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition.

Authors:  Lu Gao; Elizabeth H Rabbitt; Jennifer C Condon; Nora E Renthal; John M Johnston; Matthew A Mitsche; Pierre Chambon; Jianming Xu; Bert W O'Malley; Carole R Mendelson
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

Review 3.  Fetal-to-maternal signaling in the timing of birth.

Authors:  Carole R Mendelson; Alina P Montalbano; Lu Gao
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-11       Impact factor: 4.292

4.  Fetal Exosomal Platelet-activating Factor Triggers Functional Progesterone Withdrawal in Human Placenta.

Authors:  Kristy T Palomares; Nataliya Parobchak; Mayra Cruz Ithier; Lauren M Aleksunes; Paula M Castaño; Melody So; Revital Faro; Debra Heller; Bingbing Wang; Todd Rosen
Journal:  Reprod Sci       Date:  2020-08-11       Impact factor: 3.060

5.  Vitamin D stimulates multiple microRNAs to inhibit CRH and other pro-labor genes in human placenta.

Authors:  Bingbing Wang; Mayra Cruz Ithier; Nataliya Parobchak; Stacy M Yadava; Jay Schulkin; Todd Rosen
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

Review 6.  Multifactorial Regulation of Myometrial Contractility During Pregnancy and Parturition.

Authors:  Carole R Mendelson; Lu Gao; Alina P Montalbano
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-25       Impact factor: 5.555

7.  Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females.

Authors:  Danjie Jiang; Dawei Zheng; Lingyan Wang; Yi Huang; Haibo Liu; Leiting Xu; Qi Liao; Panpan Liu; Xinbao Shi; Zhaoyang Wang; Lebo Sun; Qingyun Zhou; Ni Li; Limin Xu; Yanping Le; Meng Ye; Guofeng Shao; Shiwei Duan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.